Christopher Hite
Chair at Royalty Pharma plc (RPRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $27.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 24SEC | RPRXRoyalty Pharma plc | Sell Plan | 96,073274,328 held (−26%) | $58.51 | $5.6M | -2.7% |
| Sep 24SEC | RPRXRoyalty Pharma plc | Sell Plan | 3,927270,401 held (−1%) | $58.93 | $231K | -3.4% |
| Aug 19SEC | RPRXRoyalty Pharma plc | Sell Plan | 100,000370,401 held (−21%) | $59.97 | $6.0M | -5.1% |
| Jul 2SEC | RPRXRoyalty Pharma plc | Sell Plan | 97,446461,953 held (−17%) | $56.50 | $5.5M | +0.8% |
| Jul 2SEC | RPRXRoyalty Pharma plc | Sell Plan | 2,554459,399 held (−1%) | $57.10 | $146K | -0.3% |
| Jul 2SEC | RPRXRoyalty Pharma plc | Sell Plan | 29,40040,600 held (−42%) | $56.44 | $1.7M | +0.9% |
| Jul 2SEC | RPRXRoyalty Pharma plc | Sell Plan | 60040,000 held (−1%) | $57.09 | $34K | -0.3% |
| Jun 25SEC | RPRXRoyalty Pharma plc | Sell Plan | 32,408676,991 held (−5%) | $54.11 | $1.8M | +5.2% |
| Jun 25SEC | RPRXRoyalty Pharma plc | Sell Plan | 117,592559,399 held (−17%) | $54.47 | $6.4M | +4.5% |
- Sell
Chair Christopher Hite sold $5.6M of RPRX at $58.51 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.
- Sell
Chair Christopher Hite sold $231K of RPRX at $58.93 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair Christopher Hite sold $6.0M of RPRX at $59.97 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair Christopher Hite sold $5.5M of RPRX at $56.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair Christopher Hite sold $146K of RPRX at $57.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair Christopher Hite sold $1.7M of RPRX at $56.44 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.